Most healthy adults should have a lipid panel every 4 to 6 years. But that baseline recommendation shifts significantly depending on your age, your cardiovascular risk level, and whether you’re taking cholesterol-lowering medication. Some people need testing every year, while others can safely wait five.
The Standard Schedule by Age
The National Heart, Lung, and Blood Institute breaks lipid testing into three age brackets. Children should be screened once between ages 9 and 11, then again between 17 and 21. If there’s a family history of high cholesterol, heart attack, or stroke, screening can start as early as age 2.
For adults aged 20 to 65, the general recommendation is every 5 years for younger adults. Once men reach 45 and women reach 55, that window tightens to every 1 to 2 years. Adults older than 65 should have their lipids checked annually.
These are the guidelines for people without known risk factors. If you have conditions that raise your cardiovascular risk, the schedule compresses further.
Risk Factors That Call for More Frequent Testing
Several conditions trigger earlier and more frequent lipid screening regardless of age. The major ones include diabetes, high blood pressure, current smoking, obesity (a BMI above 27 or 30, depending on the guideline), chronic kidney disease, HIV, chronic inflammatory conditions, and a family history of early heart disease or inherited high cholesterol. If any of these apply to you, your doctor will likely check your lipids at least once a year rather than waiting the standard four to six years.
Canadian cardiovascular guidelines use a more precise approach tied to your overall risk score. If your estimated 10-year risk of a cardiovascular event is below 5%, testing every 3 to 5 years is considered adequate. At 5% or above, annual testing is recommended.
How Your Risk Score Shapes the Timeline
A 2024 analysis published through the NIH looked at exactly how quickly cardiovascular risk climbs between tests and proposed a formula for optimizing the testing interval. The key finding: for people with a baseline 10-year risk of 15% or lower, the standard 4 to 6 year gap between tests is reasonable. Risk doesn’t shift fast enough in that range to warrant more frequent monitoring.
Once your 10-year risk exceeds 15%, it rises by roughly 1% per year. That matters because crossing the 20% threshold changes you from moderate-risk to high-risk, which affects treatment decisions. The researchers proposed a simple rule: subtract your current risk percentage from 20, and that’s approximately how many years you have before your next test should happen. A person at 16% risk would retest in 4 years. Someone at 18% should retest in 2. At 19%, testing within a year is appropriate.
Testing While on Cholesterol Medication
If you’ve just started a statin or had your dose adjusted, expect a follow-up lipid panel within about 4 to 12 weeks. This check confirms that the medication is bringing your numbers into the target range. U.S. guidelines recommend lipid monitoring every 3 to 12 months for people on therapy, while European guidelines advise annual testing once levels have stabilized.
Fasting lipid panels are particularly useful for people on statins because comparing pre-treatment and post-treatment LDL levels helps estimate how much risk reduction the medication is actually delivering. A fasting triglyceride level below 150 mg/dL while on a statin is also associated with a lower risk of statin-related diabetes, which gives your doctor another data point for managing your care.
What a Lipid Panel Measures
A standard lipid panel includes four measurements: total cholesterol, LDL (“bad”) cholesterol, HDL (“good”) cholesterol, and triglycerides. Together, these numbers paint a picture of your cardiovascular risk that no single measurement can provide on its own. Your doctor uses them alongside your age, blood pressure, smoking status, and other factors to estimate your overall risk and decide whether treatment is warranted.
Fasting vs. Non-Fasting Tests
Lipid panels have traditionally required a 9 to 12 hour fast, but that’s no longer always necessary. For initial risk screening in people who aren’t on cholesterol medication, a non-fasting sample is considered acceptable by the American College of Cardiology. Your LDL and HDL results will be reliable enough to guide the first conversation about risk.
Fasting still matters in specific situations. If your doctor suspects inherited high cholesterol (suggested by an LDL above 190 mg/dL), a fasting draw is recommended. Triglycerides are also more accurately measured in a fasting state, which is relevant if you’re being evaluated for metabolic syndrome. And if you’re already on a statin, fasting values give a cleaner comparison to your pre-treatment baseline. When a non-fasting test turns up triglycerides above 200 mg/dL, a repeat fasting test in 2 to 4 weeks is the typical next step.
Home Cholesterol Test Kits
Home test kits can be reasonably accurate, but they come with important limitations. Most measure only total cholesterol. Some add HDL and triglycerides, but LDL, the single most important number for treatment decisions, is not directly measured by home kits. Accuracy also varies by brand and depends heavily on following the instructions precisely.
A home kit can be useful for tracking trends between office visits, but it doesn’t replace a full lab-drawn lipid panel. The clinical value of lipid testing comes from interpreting all four numbers together in the context of your broader health profile, something a total cholesterol reading alone can’t deliver.